英国2013-15年基底细胞癌与皮肤鳞状细胞癌流行病学:队列研究
该队列研究利用英格兰癌症登记处病理报告诊断编码,联合苏格兰、北爱尔兰和威尔士数据,估算2013-15年英国基底细胞癌(BCC)和皮肤鳞状细胞癌(cSCC)发病率。结果显示每患者每年首次BCC和cSCC的欧洲年龄标准化发病率分别为285/10万人年和77/10万人年,2015年英国角质形成细胞癌总数超21万例,年均增长5%。
要点
- 英国2013-15年首次BCC和cSCC的EASR分别为285和77/10万人年。
- 2015年英国角质形成细胞癌总数超过21万例,年均增长5%。
- 每患者每年计数首次KC比终身仅计首次BCC/cSCC多纳入51%病例。
核心结论
- 基于改进方法学,呈现更具代表性的英国角质形成细胞癌发病率,对医疗规划至关重要。
研究设计与样本
- 队列研究,通过链接国家癌症登记处收集的病理报告诊断编码识别2013-15年KC患者,合并英格兰、苏格兰、北爱尔兰和威尔士数据。
主要发现
- 2013-15年英国每患者每年首次BCC和cSCC的EASR分别为285和77/10万人年。
- 2013至2015年BCC和cSCC年均增长率均为5%。
- 每患者每年计数首次KC比终身仅计首次BCC/cSCC多纳入51%的KC。
- 该方法可能低估真实肿瘤计数5-11%。
临床怎么用
- 改进的登记方法可提供更准确的KC发病率,有助于医疗规划和对KC流行病学的理解。
局限性
- 该方法可能低估真实肿瘤计数5-11%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), together known as keratinocyte cancers (KCs), are the commonest cancer in white ethnic populations. Recent improvements to registry data collection in England has allowed more accurate analysis of the epidemiology of BCC and cSCC and for the first time we are able to provide an accurate (representative) tumour burden for KC in the U.K. OBJECTIVES: To estimate the incidence of BCC and cSCC in the U.K. METHODS: A cohort of patients with KCs between 2013 and 2015 were identified using linkage to diagnostic codes derived from pathology reports collected into the national cancer registry. Data from England's cancer registry were combined with data from Scotland, Northern Ireland and Wales. European age-standardized incidence rates (EASRs) of the first BCC and cSCC per patient per annum (PPPA) were calculated. RESULTS: In the U.K, the EASR of the first BCC and cSCC PPPA in 2013-15 were 285 and 77 per 100 000 person years, respectively (211 120 KCs total in 2015). The mean annual percentage increase was 5% between 2013 and 2015 for both BCC and cSCC. By counting the first KC PPPA, we include an additional 51% KCs compared with the previous reporting technique which counts only the first BCC and cSCC in a patient's lifetime, yet it represents a probable underestimation of 5-11% of the true tumour count. CONCLUSIONS: Based on an improved methodology, a more representative incidence of KC is presented, which is essential to healthcare planning and will lead to improved understanding of the epidemiology of KC. What's already known about this topic? Keratinocyte cancers (KCs) are the most common cancers affecting white ethnic populations. The incidence of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) is increasing worldwide including the U.K., most commonly in elderly male Caucasian patients. These cancers are traditionally substantially underreported and frequently excluded from national cancer statistics. What does this study add? Using improved data collection methods in England and validated tumour-reporting techniques, we report the most accurate BCC and cSCC incidence data for the U.K. ever published. Identifying the first BCC and cSCC per patient per annum, the incidence of BCC and cSCC in the U.K. (excluding Wales) was 285 and 77 per 100 000 person years, respectively, between 2013 and 2015, with more than 210 000 KCs in the U.K. in 2015.
引用
- Venables ZC, Nijsten T, Wong KF, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study. Br J Dermatol. 2019. PMID: 30864158. doi:10.1111/bjd.17873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。